Drug class
Recombinant coagulation factor IX; antihaemorrhagic biologic
Mechanism of action
Replaces deficient factor IX in the intrinsic coagulation pathway. Activated factor IX, together with activated factor VIII, activates factor X, supporting thrombin generation and fibrin clot formation.
General use cases
- Treatment and prophylaxis of bleeding in patients with haemophilia B (congenital factor IX deficiency), including perioperative management, where the corresponding recombinant factor IX product is authorised.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
